Temporary liver coating may improve safety and targeting of mRNA vaccines and cancer therapies

Дата публикации: 20-08-2026 17:20:03

With the commercialization of mRNA vaccines against COVID-19, research and development into the application of mRNA in vaccines and pharmaceuticals is accelerating. In particular, it is attracting attention not only in vaccines for preventing infectious diseases but also in cancer immunotherapy.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Beyond the Petri dish: Testing tomorrow's drugs in human blood	0	7.95	27-08-2026
2	Alternative mRNA modification lets ribosomes move nearly twice as fast	0	12.07	20-08-2026
3	A hidden immune backup system could supercharge mRNA cancer vaccines	0	9.29	09-07-2026
4	FDA-approved drug may finally help immunotherapy defeat rare liver cancer	0	9.66	25-06-2026
5	Sequence changes help modified mRNA avoid protein-making errors to improve vaccine design	0	11.11	13-10-2026
6	Head-to-head comparison of three mRNA vaccines reveals differences in their stability in human blood	0	11.52	16-10-2026
7	Созданное в России покрытие для наночастиц повысит эффективность терапии рака	0	8.86	29-07-2026
8	Клинические испытания российского препарата для лечения рака печени могут начать в 2019 г.	0	0	07-02-2019
9	Interactive: A cancer vaccine is being tailored to individuals	0	12.1	19-08-2026
10	A Fentanyl Vaccine Is Now in Human Trials	5	7	07-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5.03. Источник: phys.org.